# EFNA1

## Overview
EFNA1 is a gene that encodes the protein ephrin A1, a glycosylphosphatidylinositol (GPI)-anchored ligand involved in cell signaling. Ephrin A1 is a member of the ephrin family, which interacts with Eph receptors, particularly the EphA class, to mediate bidirectional signaling crucial for various cellular processes, including cell movement, adhesion, and vascular remodeling (Pasquale2008EphEphrin; FINNE2004A). The protein exists in different isoforms due to alternative splicing, which affects its receptor binding properties and functional roles (FINNE2004A). Ephrin A1 is implicated in several physiological and pathological processes, such as T cell signaling, insulin secretion, and cancer progression, highlighting its significance in both normal cellular function and disease states (Papadakos2023Unraveling; Kaplan2012EphA2EphrinA1).

## Structure
The EFNA1 gene encodes the ephrin A1 protein, which is a glycosylphosphatidylinositol (GPI)-anchored ligand involved in cell signaling. The ephrin A1 protein is composed of five exons, with the 5' untranslated region and translation start codon located in the first exon, and the GPI-linkage sequence, stop codon, and 3' untranslated region in the last exon (FINNE2004A). A notable feature of ephrin A1 is its ability to exist in different isoforms due to alternative splicing. The primary isoform, ephrin-A1a, includes all exons, while the spliced variant, ephrin-A1b, lacks exon 3, resulting in the deletion of amino acids 131-152. This deletion significantly alters the receptor binding properties of the protein (FINNE2004A).

Ephrin A1 interacts with EphA receptors, particularly EphA2, and is involved in bidirectional signaling that affects cell movement, adhesion, and vascular remodeling (FINNE2004A). The presence or absence of exon 3 in ephrin A1 influences its molecular structure and receptor binding capacity, with ephrin-A1b showing weaker binding to EphA2 compared to ephrin-A1a (FINNE2004A). The ephrin domain is crucial for these interactions, although specific details on secondary, tertiary, or quaternary structures are not provided in the context.

## Function
Ephrin A1 (EFNA1) is a ligand for Eph receptors, particularly the EphA class, and plays a significant role in various cellular processes. In healthy human cells, ephrin A1 is involved in modulating T cell receptor (TCR) signaling in thymocytes and T cells. It inhibits interleukin-2 secretion and apoptosis in CD4+ CD8+ double-positive thymocytes, suggesting a role in the negative selection of self-reactive thymocytes (Pasquale2008EphEphrin). Ephrin A1 is also expressed in CD4+ helper T cells, where it may suppress TCR responses through reverse signaling (Pasquale2008EphEphrin).

In the context of pancreatic β cells, ephrin A1 is part of a regulatory system that modulates insulin secretion in response to glucose levels. EphA forward signaling inhibits insulin secretion, while ephrin-A reverse signaling enhances it, forming a feedback loop that adjusts insulin secretion based on glucose levels (Pasquale2008EphEphrin).

Ephrin A1 also plays a role in corneal epithelial cell migration. It restricts cell migration by activating the EphA2 receptor, which leads to the suppression of the Akt signaling pathway, crucial for cell proliferation, survival, and migration (Kaplan2012EphA2EphrinA1). This regulation is important for maintaining tissue integrity and function, particularly in wound healing processes (Kaplan2012EphA2EphrinA1).

## Clinical Significance
Alterations in the expression of the EFNA1 gene, which encodes ephrin A1, have been implicated in various pathological conditions. In the context of corneal epithelial wound healing, elevated levels of ephrin-A1 are associated with impaired wound healing, particularly in diabetic conditions. This is due to ephrin-A1's interaction with the EphA2 receptor, which inhibits the PI3K-Akt signaling pathway, crucial for cell migration and wound repair. Increased ephrin-A1 expression in diabetic corneas leads to reduced Akt activation, contributing to delayed wound healing (Kaplan2012EphA2EphrinA1).

In liver cancer, particularly hepatocellular carcinoma (HCC), ephrin-A1 is upregulated and correlates with poor prognosis. Its elevated expression is linked to increased angiogenesis and tumor progression, partly through the PI3K/Akt pathway. Ephrin-A1 also shows a strong correlation with alpha-fetoprotein (AFP) expression, contributing to the malignant characteristics of AFP-producing HCC, such as tumor growth and metastasis (Papadakos2023Unraveling).

These findings suggest that ephrin-A1 plays a significant role in the pathogenesis of both diabetic keratopathies and liver cancer, making it a potential target for therapeutic interventions in these conditions.

## Interactions
EFNA1 (ephrin A1) primarily interacts with the EphA2 receptor, a member of the Eph receptor tyrosine kinase family. This interaction is crucial for various cellular processes, including cell growth, migration, and angiogenesis. EFNA1 binds to EphA2, promoting its autophosphorylation, which triggers downstream signaling pathways that regulate these cellular activities (Cui2009EFNA1). The interaction between EFNA1 and EphA2 can lead to the rapid turnover of phosphorylated EphA2, suggesting a regulatory mechanism in cancer progression (Cui2009EFNA1).

EFNA1 exists in both a membrane-bound form and a soluble form, each having distinct effects on EphA2 localization and function. Soluble EFNA1 can activate EphA2, influencing its distribution on the cell surface and affecting cell growth (Alford2010Soluble). This soluble form can also compete with other ephrins for binding to EphA2, potentially altering its localization and signaling properties (Alford2010Soluble).

In the context of corneal epithelial cells, EFNA1-EphA2 interactions inhibit cell migration by suppressing the PI3K-Akt signaling pathway. This interaction is significant for wound healing processes, as it restricts cell motility and maintains tissue compartmentalization (Kaplan2012EphA2EphrinA1).


## References


[1. (Papadakos2023Unraveling) Stavros P. Papadakos, Ioanna E. Stergiou, Nikolina Gkolemi, Konstantinos Arvanitakis, and Stamatios Theocharis. Unraveling the significance of eph/ephrin signaling in liver cancer: insights into tumor progression and therapeutic implications. Cancers, 15(13):3434, June 2023. URL: http://dx.doi.org/10.3390/cancers15133434, doi:10.3390/cancers15133434. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers15133434)

[2. (Cui2009EFNA1) Xiang‐Dan Cui, Mi‐Jin Lee, Goung‐Ran Yu, In‐Hee Kim, Hee‐Chul Yu, Eun‐Young Song, and Dae‐Ghon Kim. Efna1 ligand and its receptor epha2: potential biomarkers for hepatocellular carcinoma. International Journal of Cancer, 126(4):940–949, November 2009. URL: http://dx.doi.org/10.1002/ijc.24798, doi:10.1002/ijc.24798. This article has 62 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/ijc.24798)

[3. (FINNE2004A) Eivind F. FINNE, Else MUNTHE, and Hans-Christian AASHEIM. A new ephrin-a1 isoform (ephrin-a1b) with altered receptor binding properties abrogates the cleavage of ephrin-a1a. Biochemical Journal, 379(1):39–46, April 2004. URL: http://dx.doi.org/10.1042/bj20031619, doi:10.1042/bj20031619. This article has 12 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20031619)

[4. (Pasquale2008EphEphrin) Elena B. Pasquale. Eph-ephrin bidirectional signaling in physiology and disease. Cell, 133(1):38–52, April 2008. URL: http://dx.doi.org/10.1016/j.cell.2008.03.011, doi:10.1016/j.cell.2008.03.011. This article has 1012 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cell.2008.03.011)

[5. (Alford2010Soluble) Spencer Alford, Adam Watson-Hurthig, Nadia Scott, Amanda Carette, Heather Lorimer, Jessa Bazowski, and Perry L Howard. Soluble ephrin a1 is necessary for the growth of hela and sk-br3 cells. Cancer Cell International, October 2010. URL: http://dx.doi.org/10.1186/1475-2867-10-41, doi:10.1186/1475-2867-10-41. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1475-2867-10-41)

[6. (Kaplan2012EphA2EphrinA1) Nihal Kaplan, Anees Fatima, Han Peng, Paul J. Bryar, Robert M. Lavker, and Spiro Getsios. Epha2/ephrin-a1 signaling complexes restrict corneal epithelial cell migration. Investigative Opthalmology &amp; Visual Science, 53(2):936, February 2012. URL: http://dx.doi.org/10.1167/iovs.11-8685, doi:10.1167/iovs.11-8685. This article has 34 citations.](https://doi.org/10.1167/iovs.11-8685)